Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Join SI Premium – FREE
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q2 EPS of ($0.55), $0.27 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference
- Alcoa closes $2.6B debt offering to fund South32 asset acquisition
- Paychex (PAYX) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
